The global pharmaceutical industry is valued at approximately $1.6 trillion, while India's market stands at $55 billion, ...

AI in drug discovery discussed at AICON’25 conference by industry experts, highlighting transformative role in pharmaceutical ...

Vishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs ...

India and Myanmar on February 14, discussed possibilities in areas of pharmaceuticals, pulses & beans, petroleum products and ...

India’s pharmaceutical industry is poised for significant growth, with its share in the global market expected to rise to 5 ...

India's Glenmark Pharmaceuticals reported third-quarter profit below estimates on Friday due to bleak U.S. demand for its long-term illness drugs.

The Indian pharma market, currently valued at around USD 55 billion, is projected to expand 2.2 to 2.4 times over the next ...

India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.

Trump announced reciprocal tariffs that could take effect against US trading partners, including India, as soon as April. The ...

Thus far in the calendar year 2025, the Nifty Pharma index has slipped 11 per cent, as against 3.7 per cent fall in Nifty 50.

Results: Glenmark Pharmaceuticals posted a net profit of ₹348 crore in Q3 FY25, reversing a ₹351 crore loss YoY. Revenue ...

Pharma stocks reacted sharply to concerns that the US might impose tariffs on pharmaceutical imports, causing the Nifty ...